As proteínas fosfatases são enzimas responsáveis pela desfosforilação de resíduos de fosfoaminoácidos, principalmente fosfotirosina e fosfoserina/treonina, o que divide esta classe de proteínas nas famílias PTP (proteína tirosina fosfatase) e PP (proteína serina/treonina fosfatase). Diversos membros da família das PPs, em particular da subfamília PPP (Phosphoprotein Phosphatase), existem como holoenzimas compostas de uma subunidade catalítica associada a uma ou mais subunidades reguladoras, que lhes conferem diversidade funcional. Neste trabalho tivemos como objetivo identificar, utilizando ensaios no sistema de duplo híbrido em leveduras, proteínas que interagem com as subunidades catalíticas das serina/treonina fosfatases do tipo 1 (DdPP1c) e do tipo 4 (DdPP4c) da ameba social D. discoideum. Varreduras de bibliotecas de cDNA das fases de crescimento e desenvolvimento da linhagem AX4 de D. discoideum com as iscas DdPP1c e uma variante mutante da DdPP1c (DdPP1cF269C) possibilitaram a identificação de pelo menos 30 genes com evidência de interação com a PP1c. A varredura das bibliotecas com a isca DdPP4 propiciou a identificação de 10 potenciais genes candidatos com evidência de interação com a PP4c. Várias dos candidatos identificados nas varreduras correspondem a genes que codificam para proteínas hipotéticas que não apresentam similaridade significativa com proteínas de função conhecida. Entre essas, identificamos e caracterizamos DdI-3, um ortólogo do inibidor-3 da PP1c de mamíferos. A interação de DdI-3 com DdPP1c foi confirmada através de ensaios independentes no sistema do duplo híbrido em leveduras. Demonstramos que DdI-3 recombinante expresso em bactérias possui atividade inibidora da DdPP1c in vitro, sendo que esta enzima tem 50% de sua atividade de fosforilase fosfatase inibida por cerca de 0,55 nM de rDdI-3. Estes dados indicam que DdI-3 é 50 vezes mais potente do que DdI-2, um ortólogo do inibidor-2 previamente caracterizado em D. discoideum. Neste trabalho, também iniciamos a construção do catálogo (The Dictyostelium Phosphatome) que irá conter todas as subunidades catalíticas e reguladoras das proteínas fosfatases codificadas no genoma de D. discoideum. Até o momento, 101 genes foram catalogados e classificados nas diferentes famílias das proteínas fosfatases, sendo 16 na família das PTPs, 26 na família das DSPs (proteína fosfatase de dupla especificidade), 15 na família das PPMs (Phosphoprotein Phosphatase Magnesium-dependent) e 31 na família das PPPs, incluindo genes codificadores de subunidades catalíticas e reguladoras. / Protein phosphatases are responsible for dephosphorylating phosphoaminoacids residues, notably phosphotyrosine and phosphoserine/threonine, thus dividing these enzymes into PTP (protein tyrosine phosphatase) and PP (protein serine/threonine phosphatase) families. Several members of the PP family, in particular those belonging to PPP (Phosphoprotein Phosphatase) are composed of one catalytic subunit and one or more regulatory subunits that provide functional diversity to the holoenzyme. In this work our goal was to identify protein interactors to type 1 (DdPP1c) and type 4 (DdPP4c) phosphatase that might behave as potential regulatory subunits of these enzymes in the social amoeba Dictyostelium discoideum. For this intent, DdPP1c, a mutant isoform of DdPP1 (DdPP1cF269C) and DdPP4c were used as baits in yeast two-hybrid based screening of D. discoideum (AX-4 strain) cDNA libraries from growth as well as developmental stages. At least 30 genes were identified as potential DdPP1c interactors while 10 genes were selected as candidates to interact to DdPP4c. Most of them are currently annotated in D. discoideum genome as hypothetical proteins of unknown function. Among the potential PP1c interactors we selected DdI-3, an ortholog of mammalian inhibitor-3. Interaction of DdI-3 and DdPP1c was confirmed by independent yeast two-hybrid assays. We demonstrated that bacterial expressed recombinant DdI-3 is effective as an inhibitor of DdPP1c in vitro, since 50% of DdPP1c phosphorylase phosphatase activity is inhibited by circa 0,55 nM of purified rDdI-3. Our results also showed that DdI-3 is 50 times more effective than DdI-2, a previously characterized PP1c inhibitor in D. discoideum. In this work we began to organize The Dictyostelium Phosphatome, a catalog of all protein phosphatases, including their catalytic and regulatory subunits, encoded in D. discoideum genome. Until now, we have classified 101 genes into the protein phosphatase families, of which 16 were classified as classic PTP, 26 as DSP (dual-specificity phosphatases), 15 as PPM (Phosphoprotein Phosphatase Magnesium-dependent) and 31 as PPP, including genes for catalytic as well as regulatory subunits.

Calmodulin is a prevalent calcium sensing protein found in all cells. Three genes exist for calmodulin and all three of these genes encode for the exact same protein sequence. Recently mutations in the amino acid sequence of calmodulin have been identified in living human patients. Thus far, patients harboring these mutations in the calmodulin sequence have only displayed an altered cardiac related phenotype. Calcineurin is involved in many key physiological processes and its activity is regulated by calcium and calmodulin. In order to assess whether or not calcineurin contributes to calmodulinopathy (a pathological state arising from dysfunctional calmodulin), a comprehensive search of relevant literature has been performed. Herein, the physiological roles of calcineurin and consequences of dysfunction have been reviewed for literature focused on the heart.

Due to heavy nutrient load and adverse climate change the occurrence of toxic cyanobacterial blooms have significantly increased during the last decades. Nodularia spumigena is one of the dominant toxic cyanobacteria which produces massive and inherent blooms in brackish water body, the Baltic Sea, particularly in late summer. Nodularia spp. are known to produce nodularins (NOD) and a range of other bioactive peptides such as spumigins and nodulopeptins, all of which have unclear function. In a recent study, three new nodulopeptins with molecular weight of 899, 901 and 917 were characterised from N. spumigena KAC 66. In the present study, N. spumigena KAC 66 was fractionated by reversed phase flash chromatography and their toxicity was determined by their lethality to Daphnia pulex and D. magna along with inhibition of protein phosphatase 1 assay (PP1). All fractions showed lethality to Daphnids and inhibitory activity against PP1, the toxicity was due to additional compounds as NOD and nodulopeptin 901 were only detected in 7 fractions. Pure NOD was lethal to D. pulex and D. magna LC50= 8.4 μg/mL and 5.0 μg/mL, respectively. The newly characterised nodulopeptin 901 was also tested against D. magna (LC50=>100 μg/mL). NOD and nodulopeptin 901 inhibited PP1 with IC50 0.038 μg/mL and 25 μg/mL, respectively. In common with many studies, the maximum amount of NOD was retained within the cells during the seven week growth experiment. In contrast, as much as ~50% of nodulopeptin 901 was detected in the growth media throughout the duration of experiments. To gain further insight on the effects of environmental stress on growth and production of bioactive metabolites in N. spumigena KAC 66, a range of parameters were investigated which included; temperature, salinity, nitrate and phosphorus. In the present study it was investigated that extreme growth conditions have a considerable effect on biomass and toxin levels by N. spumigena KAC 66. The light intensity ranged from 17.35-17.47 μmol/s/m2, 22°C and 11-20 ‰ of salinity were the optimal growth conditions to obtain maximum biomasses, intra and extracellular peptide contents. At 6.5 mg/L nitrate the maximum growth, as indicated by Chl-a and maximum concentrations of intracellular NOD and nodulopeptin 901 were detected found in week 5 and 4, respectively. Temperature had the greatest effect on peptide production. Whilst growth was similar at 22°C, 25°C and 30°C, increase in temperature had a profound effect on NOD production in that an increase from 22°C to 25°C resulted in a 50% decrease in intracellular NOD levels. At 30°C little or no NOD was detected. In contrast, whilst concentrations of nodulopeptin 901 decreased with increasing temperature, they were still detected at consistent levels suggesting they play an important role. The results from phosphate experiment showed Chl-a, cell biomass and peptide production did not show clear dependency on availability of PO-3 4. This is the first study to evaluate the effects of selected environmental parameters on NOD/nodulopeptin 901 production which ultimately may be helpful to explain the distribution, control of natural blooms and toxin levels of N. spumigena in the Baltic Sea and as well as laboratory based experiments. In an attempt further exploit cyanobacterial diversity, 20 strains were isolated from the Dian Lake and 6 from the Dead Sea. The UPLC-PDA-MS analysis of isolates, Microcystis spp. from Dian Lake, China indicated the presence of several peptides namely MC-LR, cyanopeptolin A and aerucyclamides A-D. These new isolates will be examined for biological activity and chemical characterisation in future studies.

A doença de Alzheimer (DA) é uma patologia neurodegenerativa progressiva e a forma de demência mais prevalente no mundo. As alterações fisiopatológicas da DA têm sido associadas a dois marcadores neuropatológicos clássicos: a deposição de placas de β- amilóide e a formação de emaranhados neurofibrilares da proteína tau hiperfosforilada. Porém, devido a complexidade da DA, outros mecanismos têm sido propostos como coadjuvantes no processo neurodegenerativo, entre eles eventos neuroinflamatórios, a quebra da homeostasia de sistemas de neurotransmissão e disfunção sináptica. Esta pletora de eventos patológicos parece preceder a fase de demência por um longo período onde a doença age de forma silenciosa, ou seja, onde não existem evidências sintomatológicas. Na presente tese, avançamos no entendimento de vias de sinalização associadas com a hipersforforilação da proteína tau envolvendo a disfunção da proteína fosfatase 2A e neurotoxicidade do sistema glutamatérgico. Além disso, avaliamos os radiofármacos de tomografia de emissão de pósitrons (PET) disponíveis para visualização in vivo e não invasiva da fisiopatologia da DA. Finalmente, avaliamos um novo biomarcador de PET, o [11C]ABP688, para visualizar flutuações no sistema glutamatérgico e avançamos no entendimento do impacto das células gliais no sinal do PET [18F]FDG, o radiofármaco mais utilizado na clínica atualmente para visualizar metabolismo de glicose cerebral. O [11C]ABP688 pode ser diretamente incluído em estudos clínicos e a reconceptualização do [18F]FDG proposta nesta tese pode alterar a maneira atual como vemos o metabolismo de glicose na DA e em outras doenças neurodegenerativas. Finalmente, nesta tese, avançamos em termos de mecanismos, e no contexto da busca por um diagnóstico precoce e acurado da DA. / Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most prevalent cause of dementia worldwide. The AD pathophysiological features have been associated to two main classic neuropathological markers: depositon of β-amyloid plaques and formation of neurofibrillary tangles of hyperphosphorylated tau. Due to AD complexity, however, additional mechanisms have been proposed as contributors to the neurodegenerative process, such as neuroinflammatory changes, altered neurotransmission, and synaptic dysfunction. These pathological events seem to precede the dementia phase by many years, resulting in a long silent period, i.e., a preclinical phase. In this thesis, we advanced in the understanding of signaling pathways associated with tau hyperphosphorylation, which includes dysfunction of protein phosphatase 2A (PP2A) and glutamatergic neurotoxicity. Furthermore, we underscored radiopharmaceuticals currently available for imaging AD pathophysiology in vivo and non-invasively with positron emission tomography (PET). Finally, we evaluated a new PET biomarker, [11C]ABP688, for visualizing glutamatergic fluctuations and advanced in the understating of how glial cells contribute to the [18F]FDG signal, the widely used radiopharmaceutical in clinical settings for visualizing cerebral glucose metabolism. Our findings have high translational value and direct impact in clinical settings, which can potentially alter the way we interpret glucose metabolism in AD and other neurodegenerative disorders. In summary, in this thesis, we have advanced in terms of molecular mechanisms, and in the use of PET biomarkers toward an early and accurate diagnosis of AD.

A proteína fosfatase do tipo-1 (PP1) é uma das principais proteínas serina/treonina fosfatases (PSTPs) e desempenha papeis fisiológicos tão diversos quanto importantes, tais como a regulação do metabolismo de carboidratos e do ciclo celular. A holoenzima PP1 é constituída por uma subunidade catalítica conservada (PP1c) que está associada a subunidades não-catalíticas que modulam sua localização subcelular, especificidade de substrato e atividade enzimática. Mais de 100 proteínas que interagem com a PP1c já foram identificadas em distintos organismos eucarióticos. Proteínas que interagem com a PP1c são, portanto, a chave para compreender os diferentes papéis biológicos da PP1. A subunidade catalítica da PP1 da ameba social Dictyostelium discoideum (DdPP1c) é codificada por um gene em cópia única o qual é expresso ao longo de todo o ciclo de vida desse organismo. Algumas proteínas que interagem e possivelmente modulam a atividade da PP1 de D. discoideum já foram identificadas, utilizando-se tanto buscas por similaridades na sequência genômica deste microorganismo como ensaios utilizando o sistema de duplo-híbrido em leveduras, utilizando-se a PP1c como isca. Com esta última abordagem, foram selecionados mais de 25 clones distintos de cDNA que codificam proteínas que potencialmente interagem com a DdPP1c, após varreduras de bibliotecas de cDNA de diferentes estágios de desenvolvimento de D. discoideum. Neste trabalho, nós confirmamos que o produto protéico de 11 destes clones interagem com a isca DdPP1c com base em novos ensaios de duplo-híbrido. Os demais clones codificam proteínas que não interagem com DdPP1c ou promovem auto-ativação do gene repórter. Selecionamos para estudos adicionais um clone do gene DDB_G0269300 cujo produto protéico predito de 423 de aminoácidos não tem função ainda conhecida. A sequência codificadora completa de DDB_G0269300 foi clonada para realização de novos ensaios de duplo-híbrido em leveduras, os quais confirmaram a especificidade de sua interação com DdPP1c. A proteína recombinante rDDB_G0269300 foi obtida com sucesso em bactérias, possibilitando a obtenção de anticorpos policlonais em camundongos. O anti-soro anti-rDDB_G0269300 é aparentemente específico no reconhecimento da proteína correspondente em extratos celulares de D. discoideum coletados em 12h e 16 da fase de desenvolvimento. Estes resultados coincidem com dados obtidos através de RT-qPCR que mostram aumento nos níveis dos transcritos de DDB_G0269300 entre 8h e 12h da fase de desenvolvimento, o que é indicativo da sua importância desta proteína durante esta fase do ciclo de vida de Dictyostelium como uma potencial parceira molecular da DdPP1c / Protein phosphatase type-1 (PP1) is a major protein serine/threonine phosphatase (PSTP) which plays as diverse as important physiological roles, such as regulation of carbohydrate metabolism and of cell cycle. The PP1 holoenzyme comprises a conserved catalytic subunit (PP1c) associated with non-catalytic subunits that modulate its subcellular localization, substrate specificity and enzymatic activity. More than 100 proteins that interact with PP1c have been identified in different eukaryotic organisms. Therefore proteins that interact with PP1c are key to the understanding of PP1 different biological roles. The catalytic subunit of PP1 the social amoeba Dictyostelium discoideum (DdPP1c) is encoded by a single copy gene which is expressed throughout the life cycle of this organism. Some proteins that interact with and possibly modulate the activity of D. discoideum PP1 have been identified, using both similarity searches in the genome sequence of this microorganism as yeast two-hybrid screenings using PP1c as bait. With the latter approach, we have selected more than 25 distinct cDNA clones encoding proteins that potentially interact with DdPP1c after screening D. discoideum cDNA libraries from different developmental stages. In this study, we confirmed that the protein product from 11 of these clones interact with the bait DdPP1c based on two-hybrid assays. The other clones encode proteins that either does not interact or promote self-activation of the reporter gene. The clone related to DDB_G0269300 gene that encodes a predicted protein of 423 amino acids with unknown function was selected for further studies. DDB_G0269300 full-length coding sequence was cloned and new yeast two-hybrid assays were performed confirming the specificity of the interaction with DdPP1c. The recombinant protein rDDB_G0269300 was successfully obtained in bacteria and further used for polyclonal antibodies production in mice. The antiserum anti-rDDB_G0269300 is apparently specific for recognition of the corresponding protein in D. discoideum cell extracts collected after 12h and 16h of development. These results agree with RT-qPCR data showing that the levels of DDB_G0269300 transcripts are increased between 8 h and 12 h during the development, which is indicative of its importance during this phase in Dictyostelium life cycle as a DdPP1c potential molecular partner.

The Sli15-Ipl1-Bir1 chromosomal passenger complex is essential for proper kinetochore-microtubule attachment and spindle stability in the budding yeast Saccharomyces cerevisiae. Subcellular localization of this complex during anaphase is regulated by the Cdc14 protein phosphatase, which is kept inactive in the nucleolus until anaphase onset. I show here that the predominantly nucleolar ribosome biogenesis protein Utp7 is also present at kinetochores and is required for normal organization of kinetochore proteins and proper chromosome segregation. Utp7 associates with and regulates the localization of Sli15 and Cdc14. It prevents the abnormal localization of Sli15 on cytoplasmic microtubules, the premature concentration of Sli15 on the pre-anaphase spindle, and the premature nucleolar release of Cdc14 before anaphase onset. Utp7 regulates Sli15 localization not entirely through its effect on Cdc14. Furthermore, the mitotic exit block caused by Cdc14 inactivation is relieved partially by the simultaneous inactivation of Utp7. Thus, Utp7 is a multifunctional protein that plays essential roles in the vital cellular processes of ribosome biogenesis, chromosome segregation and cell cycle control. Protein phosphatase 1, Glc7 opposes in vivo functions of the Ipl1-Sli15-Bir1 kinase complex in budding yeast. I show here Scd5- a targeting subunit of Glc7 that regulates endocytosis/cortical actin organization and undergoes nuclear-cytoplasmic shuttling- is present at kinetochores. Ipl1 associates with both Glc7 and Scd5. The scd5-PP1[Delta]2 mutation, which disrupts the association between Glc7 and Scd5, also disrupts the association between Ipl1 and Scd5-Glc7 without affecting the kinetochore localization of these proteins. Genetic studies suggest that Scd5 may positively regulate both Glc7 phosphatase and the Ipl1 kinase complex. In accordance, Scd5 stimulates in vitro kinase activity of Ipl1. scd5-PP1[Delta]2 cells missegregate chromosomes severely due to several defects: i) at least one of sister kinetochores appears not attached to microtubule. ii) sister chromatids are persistently cohesed through anaphase. iii) Sli15 is hyperphosphorylated and less abundant on the anaphase spindle resulting in unstable mitotic spindle. These results together suggest that Scd5 functions in diverse processes that are essential for faithful chromosome segregation. How Scd5 coordinately regulates two apparently antagonistic enzymatic activities of Ipl1 and Glc7 remains to be determined. / text

La consommation répétée de drogues induit une plasticité cérébrale, qui pourrait sous-tendre le développement de la dépendance. La protéine phosphatase de type 1 (PP1) étant un acteur majeur de ces processus, nous nous sommes intéressés à sa régulation par la cocaïne. Nous avons montré qu’un traitement chronique par la cocaïne induit la répression du gène codant la sous-unitécatalytique β de PP1 (PP1Cβ), via l’hyperméthylation de sa région promotrice et le recrutement de la protéine de liaison à l’ADN méthylé, Mecp2. Cette répression, observée dans les principales structures du système de récompense du Rat, pourrait favoriser l’état phosphorylé des récepteurs NMDA et AMPA du glutamate et du facteur de transcription CREB, potentialisant ainsi les effets de la cocaïne. PP1 étant souvent considérée comme un régulateur négatif de la mémoire, sa répression pourrait également favoriser la ‘mémorisation’ du contexte et des habitudes liés à la drogue. L’expression de PP1Cβ a ensuite été analysée en réponse à des injections passives ou volontaires de cocaïne dans un test de conditionnement opérant, l’auto-administration intraveineuse. Étonnamment, une répression similaire de PP1Cβ est observée quel que soit le mode d’administration de la cocaïne. Son expression est par contre différente lorsque la cocaïne est remplacée par de la nourriture : elle est induite par le conditionnement opérant, sans être affectée par une distribution passive de nourriture. Le gène PP1Cβ participe donc sans doute aux neuroadaptations différentielles induites par les drogues et les récompenses naturelles, ouvrant ainsi de nouvelles perspectives dans la compréhension des effets à long terme des drogues. / Repeated intake of drugs of abuse is known to induce brain plasticity, which may underlie the development of drug addiction. Protein phosphatase type-1 (PP1) is one of the key proteins involved in brain plasticity mechanisms. We therefore studied its regulation in response to repeated cocaine intake by rats. The gene encoding the β catalytic subunit of PP1 (PP1Cβ) was found to be repressed by chronic cocaine treatment, through a mechanism involving DNA methylation of the PP1Cβ 5’-end followed by the recruitment of the methyl binding protein Mecp2. This repression was observed in the major brain structures of the reward system and probably favors the phosphorylation state of NMDA and AMPA glutamatergic receptors and of CREB transcriptionfactor, thus further increasing cocaine effects. PP1 is also known as a negative regulator of memory formation. Its repression by cocaine may therefore potentiate the ‘memorization’ of cocaine-related habits and context. PP1Cβ expression was next compared in response to passive vs voluntary cocaine injections in an operant intravenous cocaine self-administration paradigm. Surprisingly, a similar repression of PP1Cβ was found, independently on the cocaine administration mode. A completely different pattern of expression was observed when cocaine administration was replaced by food intake, as PP1Cβ expression was increased during food operant self-administration, but not in response to passive food delivery. Taken together, our data suggest that PP1Cβ participates to the differential neuroadaptations induced by drugs of abuse and natural rewards. They shed somenew light on the long-term mechanisms induced by drugs of abuse.

A doença de Alzheimer (DA) é uma patologia neurodegenerativa progressiva e a forma de demência mais prevalente no mundo. As alterações fisiopatológicas da DA têm sido associadas a dois marcadores neuropatológicos clássicos: a deposição de placas de β- amilóide e a formação de emaranhados neurofibrilares da proteína tau hiperfosforilada. Porém, devido a complexidade da DA, outros mecanismos têm sido propostos como coadjuvantes no processo neurodegenerativo, entre eles eventos neuroinflamatórios, a quebra da homeostasia de sistemas de neurotransmissão e disfunção sináptica. Esta pletora de eventos patológicos parece preceder a fase de demência por um longo período onde a doença age de forma silenciosa, ou seja, onde não existem evidências sintomatológicas. Na presente tese, avançamos no entendimento de vias de sinalização associadas com a hipersforforilação da proteína tau envolvendo a disfunção da proteína fosfatase 2A e neurotoxicidade do sistema glutamatérgico. Além disso, avaliamos os radiofármacos de tomografia de emissão de pósitrons (PET) disponíveis para visualização in vivo e não invasiva da fisiopatologia da DA. Finalmente, avaliamos um novo biomarcador de PET, o [11C]ABP688, para visualizar flutuações no sistema glutamatérgico e avançamos no entendimento do impacto das células gliais no sinal do PET [18F]FDG, o radiofármaco mais utilizado na clínica atualmente para visualizar metabolismo de glicose cerebral. O [11C]ABP688 pode ser diretamente incluído em estudos clínicos e a reconceptualização do [18F]FDG proposta nesta tese pode alterar a maneira atual como vemos o metabolismo de glicose na DA e em outras doenças neurodegenerativas. Finalmente, nesta tese, avançamos em termos de mecanismos, e no contexto da busca por um diagnóstico precoce e acurado da DA. / Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most prevalent cause of dementia worldwide. The AD pathophysiological features have been associated to two main classic neuropathological markers: depositon of β-amyloid plaques and formation of neurofibrillary tangles of hyperphosphorylated tau. Due to AD complexity, however, additional mechanisms have been proposed as contributors to the neurodegenerative process, such as neuroinflammatory changes, altered neurotransmission, and synaptic dysfunction. These pathological events seem to precede the dementia phase by many years, resulting in a long silent period, i.e., a preclinical phase. In this thesis, we advanced in the understanding of signaling pathways associated with tau hyperphosphorylation, which includes dysfunction of protein phosphatase 2A (PP2A) and glutamatergic neurotoxicity. Furthermore, we underscored radiopharmaceuticals currently available for imaging AD pathophysiology in vivo and non-invasively with positron emission tomography (PET). Finally, we evaluated a new PET biomarker, [11C]ABP688, for visualizing glutamatergic fluctuations and advanced in the understating of how glial cells contribute to the [18F]FDG signal, the widely used radiopharmaceutical in clinical settings for visualizing cerebral glucose metabolism. Our findings have high translational value and direct impact in clinical settings, which can potentially alter the way we interpret glucose metabolism in AD and other neurodegenerative disorders. In summary, in this thesis, we have advanced in terms of molecular mechanisms, and in the use of PET biomarkers toward an early and accurate diagnosis of AD.

A doença de Alzheimer (DA) é uma patologia neurodegenerativa progressiva e a forma de demência mais prevalente no mundo. As alterações fisiopatológicas da DA têm sido associadas a dois marcadores neuropatológicos clássicos: a deposição de placas de β- amilóide e a formação de emaranhados neurofibrilares da proteína tau hiperfosforilada. Porém, devido a complexidade da DA, outros mecanismos têm sido propostos como coadjuvantes no processo neurodegenerativo, entre eles eventos neuroinflamatórios, a quebra da homeostasia de sistemas de neurotransmissão e disfunção sináptica. Esta pletora de eventos patológicos parece preceder a fase de demência por um longo período onde a doença age de forma silenciosa, ou seja, onde não existem evidências sintomatológicas. Na presente tese, avançamos no entendimento de vias de sinalização associadas com a hipersforforilação da proteína tau envolvendo a disfunção da proteína fosfatase 2A e neurotoxicidade do sistema glutamatérgico. Além disso, avaliamos os radiofármacos de tomografia de emissão de pósitrons (PET) disponíveis para visualização in vivo e não invasiva da fisiopatologia da DA. Finalmente, avaliamos um novo biomarcador de PET, o [11C]ABP688, para visualizar flutuações no sistema glutamatérgico e avançamos no entendimento do impacto das células gliais no sinal do PET [18F]FDG, o radiofármaco mais utilizado na clínica atualmente para visualizar metabolismo de glicose cerebral. O [11C]ABP688 pode ser diretamente incluído em estudos clínicos e a reconceptualização do [18F]FDG proposta nesta tese pode alterar a maneira atual como vemos o metabolismo de glicose na DA e em outras doenças neurodegenerativas. Finalmente, nesta tese, avançamos em termos de mecanismos, e no contexto da busca por um diagnóstico precoce e acurado da DA. / Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most prevalent cause of dementia worldwide. The AD pathophysiological features have been associated to two main classic neuropathological markers: depositon of β-amyloid plaques and formation of neurofibrillary tangles of hyperphosphorylated tau. Due to AD complexity, however, additional mechanisms have been proposed as contributors to the neurodegenerative process, such as neuroinflammatory changes, altered neurotransmission, and synaptic dysfunction. These pathological events seem to precede the dementia phase by many years, resulting in a long silent period, i.e., a preclinical phase. In this thesis, we advanced in the understanding of signaling pathways associated with tau hyperphosphorylation, which includes dysfunction of protein phosphatase 2A (PP2A) and glutamatergic neurotoxicity. Furthermore, we underscored radiopharmaceuticals currently available for imaging AD pathophysiology in vivo and non-invasively with positron emission tomography (PET). Finally, we evaluated a new PET biomarker, [11C]ABP688, for visualizing glutamatergic fluctuations and advanced in the understating of how glial cells contribute to the [18F]FDG signal, the widely used radiopharmaceutical in clinical settings for visualizing cerebral glucose metabolism. Our findings have high translational value and direct impact in clinical settings, which can potentially alter the way we interpret glucose metabolism in AD and other neurodegenerative disorders. In summary, in this thesis, we have advanced in terms of molecular mechanisms, and in the use of PET biomarkers toward an early and accurate diagnosis of AD.

A proteína fosfatase do tipo-1 (PP1) é uma das principais proteínas serina/treonina fosfatases (PSTPs) e desempenha papeis fisiológicos tão diversos quanto importantes, tais como a regulação do metabolismo de carboidratos e do ciclo celular. A holoenzima PP1 é constituída por uma subunidade catalítica conservada (PP1c) que está associada a subunidades não-catalíticas que modulam sua localização subcelular, especificidade de substrato e atividade enzimática. Mais de 100 proteínas que interagem com a PP1c já foram identificadas em distintos organismos eucarióticos. Proteínas que interagem com a PP1c são, portanto, a chave para compreender os diferentes papéis biológicos da PP1. A subunidade catalítica da PP1 da ameba social Dictyostelium discoideum (DdPP1c) é codificada por um gene em cópia única o qual é expresso ao longo de todo o ciclo de vida desse organismo. Algumas proteínas que interagem e possivelmente modulam a atividade da PP1 de D. discoideum já foram identificadas, utilizando-se tanto buscas por similaridades na sequência genômica deste microorganismo como ensaios utilizando o sistema de duplo-híbrido em leveduras, utilizando-se a PP1c como isca. Com esta última abordagem, foram selecionados mais de 25 clones distintos de cDNA que codificam proteínas que potencialmente interagem com a DdPP1c, após varreduras de bibliotecas de cDNA de diferentes estágios de desenvolvimento de D. discoideum. Neste trabalho, nós confirmamos que o produto protéico de 11 destes clones interagem com a isca DdPP1c com base em novos ensaios de duplo-híbrido. Os demais clones codificam proteínas que não interagem com DdPP1c ou promovem auto-ativação do gene repórter. Selecionamos para estudos adicionais um clone do gene DDB_G0269300 cujo produto protéico predito de 423 de aminoácidos não tem função ainda conhecida. A sequência codificadora completa de DDB_G0269300 foi clonada para realização de novos ensaios de duplo-híbrido em leveduras, os quais confirmaram a especificidade de sua interação com DdPP1c. A proteína recombinante rDDB_G0269300 foi obtida com sucesso em bactérias, possibilitando a obtenção de anticorpos policlonais em camundongos. O anti-soro anti-rDDB_G0269300 é aparentemente específico no reconhecimento da proteína correspondente em extratos celulares de D. discoideum coletados em 12h e 16 da fase de desenvolvimento. Estes resultados coincidem com dados obtidos através de RT-qPCR que mostram aumento nos níveis dos transcritos de DDB_G0269300 entre 8h e 12h da fase de desenvolvimento, o que é indicativo da sua importância desta proteína durante esta fase do ciclo de vida de Dictyostelium como uma potencial parceira molecular da DdPP1c / Protein phosphatase type-1 (PP1) is a major protein serine/threonine phosphatase (PSTP) which plays as diverse as important physiological roles, such as regulation of carbohydrate metabolism and of cell cycle. The PP1 holoenzyme comprises a conserved catalytic subunit (PP1c) associated with non-catalytic subunits that modulate its subcellular localization, substrate specificity and enzymatic activity. More than 100 proteins that interact with PP1c have been identified in different eukaryotic organisms. Therefore proteins that interact with PP1c are key to the understanding of PP1 different biological roles. The catalytic subunit of PP1 the social amoeba Dictyostelium discoideum (DdPP1c) is encoded by a single copy gene which is expressed throughout the life cycle of this organism. Some proteins that interact with and possibly modulate the activity of D. discoideum PP1 have been identified, using both similarity searches in the genome sequence of this microorganism as yeast two-hybrid screenings using PP1c as bait. With the latter approach, we have selected more than 25 distinct cDNA clones encoding proteins that potentially interact with DdPP1c after screening D. discoideum cDNA libraries from different developmental stages. In this study, we confirmed that the protein product from 11 of these clones interact with the bait DdPP1c based on two-hybrid assays. The other clones encode proteins that either does not interact or promote self-activation of the reporter gene. The clone related to DDB_G0269300 gene that encodes a predicted protein of 423 amino acids with unknown function was selected for further studies. DDB_G0269300 full-length coding sequence was cloned and new yeast two-hybrid assays were performed confirming the specificity of the interaction with DdPP1c. The recombinant protein rDDB_G0269300 was successfully obtained in bacteria and further used for polyclonal antibodies production in mice. The antiserum anti-rDDB_G0269300 is apparently specific for recognition of the corresponding protein in D. discoideum cell extracts collected after 12h and 16h of development. These results agree with RT-qPCR data showing that the levels of DDB_G0269300 transcripts are increased between 8 h and 12 h during the development, which is indicative of its importance during this phase in Dictyostelium life cycle as a DdPP1c potential molecular partner.